Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
PT-141 is a cyclic peptide agonist of melanocortin receptor 4 (MC4R) and an analog of α-melanocyte stimulating hormone (α-MSH; Item No. 29923).1 It binds to MC3R and MC4R and increases intracellular cAMP levels in HEK293 cells expressing MC4R. It increases dopamine release in the medial preoptic area (mPOA) of the hypothalamus in female rats.2 PT-141 (100 and 200 µg/kg) increases the number of solicitations, an appetitive sexual behavior, by ovariectomized estrogen- and progesterone-primed female rats. Intranasal administration of PT-141 (50 µg/kg) induces penile erections in male rats.1 Formulations containing PT-141 have been used in the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.
WARNING This product is not for human or veterinary use.
1. PT-
2. Bremelanotide: An overview of preclinical CNS effects on female sexual function. J. Sex Med. 4(Suppl 4), 269-279 (2007).